Skip to main content
Year archive

Galapagos NV — 2017 filings

All 196 regulatory filings released by Galapagos NV (GLPG) in 2017, sourced directly from the official regulator.

196 Filings
2017 Period
2017 filings (196)
Filing Released Lang
Transparency notification
Major Shareholding Notification
2017-12-18 English
Transparency notification
Major Shareholding Notification
2017-12-18 English
GILD_TP_ENG.pdf
Declaration of Voting Results & Voting Rights Announcements
2017-12-18 English
GILD TP _NL.pdf
Major Shareholding Notification
2017-12-18 Dutch
GILD_TP_ENG.pdf
Major Shareholding Notification
2017-12-18 English
GILD TP _NL.pdf
Major Shareholding Notification
2017-12-18 Dutch
6-K Filing
Foreign Filer Report
2017-12-18 English
Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries
Capital/Financing Update
2017-12-15 English
Galapagos exercises co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries
Regulatory Filings
2017-12-15 English
6-K Filing
Foreign Filer Report
2017-12-15 English
Transparency notification
Major Shareholding Notification
2017-12-12 English
Transparency notification
Major Shareholding Notification
2017-12-12 English
6-K Filing
Foreign Filer Report
2017-12-12 English
6-K Filing
Foreign Filer Report
2017-12-12 English
FMR_TP_7DEC2017_def.pdf
Major Shareholding Notification
2017-12-11 English
FMR TP _7DEC2017_NL_def.pdf
Declaration of Voting Results & Voting Rights Announcements
2017-12-11 Dutch
Galapagos to enter NASDAQ Biotech Index
Regulatory Filings
2017-12-11 English
Galapagos to enter NASDAQ Biotech Index
Regulatory Filings
2017-12-11 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-11-24 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-11-24 English
6-K Filing
Foreign Filer Report
2017-11-24 English
Share Capital Increase - 23 November 2017_EN.pdf
Share Issue/Capital Change
2017-11-23 English
Share Capital Increase - 23 November 2017_NL.pdf
Share Issue/Capital Change
2017-11-23 Dutch
Galapagos initiates Phase 1 study with novel CF corrector GLPG3221
Regulatory Filings
2017-11-22 English
Galapagos initiates Phase 1 study with novel CF corrector GLPG3221
Regulatory Filings
2017-11-22 English
6-K Filing
Foreign Filer Report
2017-11-22 English
ALBATROSS with GLPG2222 shows positive clinical results in CF patients
Earnings Release Q4 2017
2017-11-20 English
ALBATROSS with GLPG2222 shows positive clinical results in CF patients
Earnings Release Q4 2017
2017-11-20 English
6-K Filing
Foreign Filer Report
2017-11-20 English
Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study
Regulatory Filings
2017-11-06 English
Consistent safety findings and durable activity with filgotinib treatment of rheumatoid arthritis patients up to week 84 in DARWIN 3 study
Investor Presentation
2017-11-06 English
6-K Filing
Foreign Filer Report
2017-11-06 English
Galapagos moving forward in CF programs at NACFC 2017
Regulatory Filings
2017-11-02 English
Galapagos moving forward in CF programs at NACFC 2017
Report Publication Announcement
2017-11-02 English
6-K Filing
Foreign Filer Report
2017-11-02 English
PR Q3 2017_ENG.pdf
Earnings Release 9M 2017
2017-11-02 English
PR Q3 2017_NL.pdf
Earnings Release 9M 2017
2017-11-02 Dutch
6-K Filing
Foreign Filer Report
2017-10-30 English
Galapagos Q3: clinical success with GLPG1690 and MOR106 highlights strength of deep pipeline
Earnings Release 9M 2017
2017-10-27 English
Galapagos Q3: clinical success with GLPG1690 and MOR106 highlights strength of deep pipeline
Earnings Release 9M 2017
2017-10-27 English
Galapagos Q3 clinical success with GLPG1690 and MOR106 highlights strength of deep pipeline.pdf
Earnings Release 9M 2017
2017-10-26 English
Galapagos Q3 klinisch succes van GLPG1690 en MOR106 benadrukt sterkte van onze brede pijplijn.pdf
Earnings Release 9M 2017
2017-10-26 Dutch
Q3 report 2017.pdf
Interim / Quarterly Report 9M 2017
2017-10-26 English
Q3 verslag 2017.pdf
Interim / Quarterly Report 9M 2017
2017-10-26 Dutch
Galapagos and MorphoSys report first promising signs of clinical activity in a Phase 1 study with IL-17C antibody MOR106 in atopic dermatitis patients
Earnings Release Q3 2017
2017-09-27 English
Galapagos and MorphoSys report first promising signs of clinical activity in a Phase 1 study with IL-17C antibody MOR106 in atopic dermatitis patients
Earnings Release Q3 2017
2017-09-27 English
6-K Filing
Foreign Filer Report
2017-09-27 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-09-22 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-09-22 English
6-K Filing
Foreign Filer Report
2017-09-22 English
Share Capital Increase - 21 September 2017_EN.pdf
Share Issue/Capital Change
2017-09-21 English
Share Capital Increase - 21 September 2017_NL.pdf
Share Issue/Capital Change
2017-09-21 Dutch
GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial
Earnings Release FY 2017
2017-08-10 English
GLPG1690 halts disease progression in IPF patients in FLORA Phase 2a trial
Regulatory Filings
2017-08-10 English
6-K Filing
Foreign Filer Report
2017-08-10 English
GLPG1690 stopt ziekteprogressie in IPF patiënten in de FLORA Fase 2a studie
Earnings Release Q3 2017
2017-08-09 Dutch
GLPG1690 halts disease progression in IPF patients
Regulatory Filings
2017-08-09 English
GLPG1690 stopt ziekteprogressie in IPF patiënten in de FLORA Fase 2a studie
Earnings Release Q3 2017
2017-08-09 Dutch
6-K Filing
Foreign Filer Report
2017-07-31 English
Servier licenses GLPG1972 in osteoarthritis from Galapagos
Regulatory Filings
2017-07-28 English
Servier licenses GLPG1972 in osteoarthritis from Galapagos
Regulatory Filings
2017-07-28 English
Solid financials support R&D progress
Earnings Release H1 2017
2017-07-28 English
Solid financials support R&D progress
Earnings Release H1 2017
2017-07-28 English
6-K Filing
Foreign Filer Report
2017-07-28 English
H1 Report ENG.pdf
Interim / Quarterly Report H1 2017
2017-07-27 English
H1 Report NL.pdf
Interim / Quarterly Report H1 2017
2017-07-27 Dutch
New Phase 2 study with filgotinib in non-infectious uveitis
Regulatory Filings
2017-07-05 English
New Phase 2 study with filgotinib in non-infectious uveitis
Regulatory Filings
2017-07-05 English
6-K Filing
Foreign Filer Report
2017-07-05 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-06-21 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-06-21 English
6-K Filing
Foreign Filer Report
2017-06-21 English
Galapagos' R&D Update 2017: rapidly advancing our product candidates
Earnings Release Q2 2017
2017-06-20 English
Galapagos' R&D Update 2017: rapidly advancing our product candidates
Earnings Release H1 2017
2017-06-20 English
6-K Filing
Foreign Filer Report
2017-06-20 English
Galapagos’ R&D Update 2017: rapidly advancing our product candidates
Investor Presentation
2017-06-20 English
Galapagos’ R&D Update 2017: snelle ontwikkeling van onze kandidaatmedicijnen
Earnings Release H1 2017
2017-06-20 Dutch
Share Capital Increase - 20 June 2017_EN.pdf
Share Issue/Capital Change
2017-06-20 English
Share Capital Increase - 20 June 2017_NL.pdf
Share Issue/Capital Change
2017-06-20 Dutch
S-8 Filing
Registration Form
2017-05-22 English
Galapagos creates new warrant plan
Share Issue/Capital Change
2017-05-18 English
Galapagos creates new warrant plan
Share Issue/Capital Change
2017-05-18 English
6-K Filing
Foreign Filer Report
2017-05-18 English
Galapagos to hold Annual R&D Update 2017 on 20 June
Report Publication Announcement
2017-05-17 English
Galapagos to hold Annual R&D Update 2017 on 20 June
Report Publication Announcement
2017-05-17 English
Warrant Plan 2017_BoD Report_583_E.pdf
Capital/Financing Update
2017-05-17 English
Warrant Plan 2017_BoD Report_583_D.pdf
Share Issue/Capital Change
2017-05-17 Dutch
Warrant Plan 2017_BoD Report_596-598_E.pdf
Share Issue/Capital Change
2017-05-17 English
Warrant Plan 2017_BoD Report_596-598_D.pdf
Capital/Financing Update
2017-05-17 Dutch
Seven abstracts on filgotinib accepted by EULAR 2017
Earnings Release Q2 2017
2017-05-16 English
Seven abstracts on filgotinib accepted by EULAR 2017
Regulatory Filings
2017-05-16 English
6-K Filing
Foreign Filer Report
2017-05-16 English
6-K Filing
Foreign Filer Report
2017-05-08 English
6-K Filing
Foreign Filer Report
2017-05-02 English
Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI
Earnings Release Q2 2017
2017-05-01 English
Galapagos presents pre-clinical data with selective ADAMTS-5 inhibitor GLPG1972 for osteoarthritis at OARSI
Regulatory Filings
2017-05-01 English
Galapagos reports first quarter 2017 results
Earnings Release Q1 2017
2017-04-28 English
Galapagos reports first quarter 2017 results
Earnings Release Q1 2017
2017-04-28 English
6-K Filing
Foreign Filer Report
2017-04-28 English
Q1 17 Report.pdf
Interim / Quarterly Report Q1 2017
2017-04-27 English
Q1 17 Verslag.pdf
Interim / Quarterly Report Q1 2017
2017-04-27 Dutch
Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus
Regulatory Filings
2017-04-26 English
Galapagos announces new Phase 2 Proof-of-Concept study with filgotinib in cutaneous lupus erythematosus
Regulatory Filings
2017-04-26 English
6-K Filing
Foreign Filer Report
2017-04-26 English
Minutes_Annual-en.pdf
AGM Information
2017-04-26 English
Minutes_gewonealgemenevergadering-nl.pdf
AGM Information
2017-04-26 Dutch
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €363.9 million
Share Issue/Capital Change
2017-04-24 English
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €363.9 million
Share Issue/Capital Change
2017-04-24 English
Galapagos announces capital increase
Share Issue/Capital Change
2017-04-24 English
Galapagos announces capital increase
Share Issue/Capital Change
2017-04-24 English
6-K Filing
Foreign Filer Report
2017-04-24 English
6-K Filing
Foreign Filer Report
2017-04-24 English
3. Broadway II - Closing ENG.pdf
Capital/Financing Update
2017-04-21 English
3. Broadway II - Closing NL.pdf
Capital/Financing Update
2017-04-21 Dutch
4. Broadway II - New Denominator ENG.pdf
Share Issue/Capital Change
2017-04-21 English
4. Broadway II - New Denominator NL.pdf
Share Issue/Capital Change
2017-04-21 Dutch
Galapagos announces launch of proposed public offering
Share Issue/Capital Change
2017-04-18 English
Galapagos announces launch of proposed public offering
Capital/Financing Update
2017-04-18 English
Galapagos raises $338 million gross proceeds in a U.S. public offering
Share Issue/Capital Change
2017-04-18 English
Galapagos raises $338 million gross proceeds in a U.S. public offering
Share Issue/Capital Change
2017-04-18 English
424B5 Filing
Prospectus
2017-04-18 English
6-K Filing
Foreign Filer Report
2017-04-18 English
1. Broadway II - Launch ENG.pdf
Capital/Financing Update
2017-04-18 English
1. Broadway II - Launch NL.pdf
Share Issue/Capital Change
2017-04-18 Dutch
GLPG transaction Pricing ENG.docx.pdf
Capital/Financing Update
2017-04-18 English
GLPG transaction Pricing NL.docx.pdf
Capital/Financing Update
2017-04-18 Dutch
Broadway II_Board Report 596_ENG_Website.pdf
Capital/Financing Update
2017-04-17 English
Broadway II_Board Report 596_NED_Website.pdf
Capital/Financing Update
2017-04-17 Dutch
424B5 Filing
Prospectus
2017-04-17 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-04-07 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2017-04-07 English
6-K Filing
Foreign Filer Report
2017-04-07 English
Galapagos doses first psoriatic arthritis patient with filgotinib
Regulatory Filings
2017-04-06 English
Galapagos doses first psoriatic arthritis patient with filgotinib
Legal Proceedings Report
2017-04-06 English
6-K Filing
Foreign Filer Report
2017-04-06 English
Share Capital Increase - 6 April 2017_EN.pdf
Share Issue/Capital Change
2017-04-06 English
Share Capital Increase - 6 April 2017_NL.pdf
Share Issue/Capital Change
2017-04-06 Dutch
Galapagos doses first psoriatic arthritis patient with filgotinib
Regulatory Filings
2017-04-05 English
Galapagos behandelt eerste psoriatic arthritis patient met filgotinib
Legal Proceedings Report
2017-04-05 Dutch
Galapagos announces three new Phase 2 Proof-of-Concept studies with filgotinib
Regulatory Filings
2017-04-04 English
Galapagos announces three new Phase 2 Proof-of-Concept studies with filgotinib
Regulatory Filings
2017-04-04 English
6-K Filing
Foreign Filer Report
2017-04-04 English
Publication of the annual report and invitation to the annual and extraordinary shareholders' meetings
Report Publication Announcement
2017-03-24 English
Publication of the annual report and invitation to the annual and extraordinary shareholders' meetings
Report Publication Announcement
2017-03-24 English
nxr_glpg_ar16_final_EN_bw.pdf
Annual Report FY 2016
2017-03-24 English
nxr_glpg_ar16_final_NL_bw.pdf
Annual Report FY 2016
2017-03-24 Dutch
6-K Filing
Foreign Filer Report
2017-03-23 English
20-F Filing
Annual Report FY 2016
2017-03-23 English
8. AGM-EGM 25 April 2017 - Shares and Voting Rights - Dutch&English.pdf
Share Issue/Capital Change
2017-03-23 Dutch
3. AGM-EGM 25 April 2017 - Attendance Notification Form - Dutch&English.pdf
AGM Information
2017-03-23 Dutch
6. Auditor report - Non-Conso Galapagos NV 31.12.2016 - English.pdf
Audit Report / Information FY 2016
2017-03-23 English
7. BoD Report - 604 - Authorized Capital - Dutch.pdf
Capital/Financing Update
2017-03-23 Dutch
7. BoD Report - 604 - Authorized Capital - English.pdf
Capital/Financing Update
2017-03-23 English
4. AR 16_final_NL.pdf
Annual Report FY 2016
2017-03-23 Dutch
4. AR 16_final_EN.pdf
Annual Report FY 2016
2017-03-23 English
6. Auditor report - Non-Conso Galapagos NV 31.12.2016 - Dutch.pdf
Audit Report / Information FY 2016
2017-03-23 Dutch
5. Non-consolidated financial statements.pdf
Annual Report FY 2016
2017-03-23 English
2. AGM 25 April 2017 - Proxy Form - Dutch&English.pdf
AGM Information
2017-03-23 Dutch
1. AGM-EGM 25 April 2017 - Convening Notice - English.pdf
Proxy Solicitation & Information Statement
2017-03-23 English
1. AGM-EGM 25 April 2017 - Convening Notice - Dutch.pdf
AGM Information
2017-03-23 Dutch
Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067
Earnings Release Q1 2017
2017-03-22 English
Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067
Regulatory Filings
2017-03-22 English
6-K Filing
Foreign Filer Report
2017-03-22 English
Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067
Earnings Release FY 2017
2017-03-22 English
Galapagos start Fase 1 studie met CF medicijn GLPG3067
Legal Proceedings Report
2017-03-22 Dutch
New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease
Regulatory Filings
2017-03-10 English
New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease
Regulatory Filings
2017-03-10 English
6-K Filing
Foreign Filer Report
2017-03-10 English
Galapagos reports strong financial results and newsflow-rich pipeline
Earnings Release FY 2016
2017-02-24 English
Galapagos reports strong financial results and newsflow-rich pipeline
Audit Report / Information FY 2016
2017-02-24 English
Galapagos rapporteert sterke jaarcijfers en een veelbelovende pijplijn
Annual Report FY 2016
2017-02-24 Dutch
Galapagos rapporteert sterke jaarcijfers en een veelbelovende pijplijn
Earnings Release FY 2016
2017-02-24 Dutch
Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451
Regulatory Filings
2017-02-24 English
Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451
Regulatory Filings
2017-02-24 English
6-K Filing
Foreign Filer Report
2017-02-24 English
6-K Filing
Foreign Filer Report
2017-02-24 English
FY2016_FINANCIAL-TABLES_EN.pdf
Audit Report / Information FY 2016
2017-02-23 English
FY2016_FINANCIAL-TABLES_NL.pdf
Annual Report FY 2016
2017-02-23 Dutch
FY2016_ENG .pdf
Earnings Release FY 2016
2017-02-23 English
FY2016_NL.pdf
Earnings Release FY 2016
2017-02-23 Dutch
SC 13G/A Filing
Major Shareholding Notification
2017-02-15 English
SC 13G/A Filing
Major Shareholding Notification
2017-02-09 English
Galapagos doses first patient with novel CF corrector GLPG2222
Regulatory Filings
2017-02-02 English
Galapagos doses first patient with novel CF corrector GLPG2222
Legal Proceedings Report
2017-02-02 English
6-K Filing
Foreign Filer Report
2017-02-02 English
Galapagos doses first patient with novel CF corrector GLPG2222
Regulatory Filings
2017-02-01 English
Galapagos start CF patiëntenstudie met nieuwe corrector GLPG2222
Regulatory Filings
2017-02-01 Dutch
S-8 Filing
Registration Form
2017-01-27 English
Galapagos creates new warrant plan
Share Issue/Capital Change
2017-01-23 English
Galapagos creates new warrant plan
Remuneration Information
2017-01-23 English
6-K Filing
Foreign Filer Report
2017-01-23 English
583E+596E.pdf
Share Issue/Capital Change
2017-01-20 English
583D+596D.pdf
Remuneration Information
2017-01-20 Dutch
Dr. Walid Abi-Saab joins Galapagos as Chief Medical Officer
Board/Management Information
2017-01-18 English
Dr. Walid Abi-Saab joins Galapagos as Chief Medical Officer
Board/Management Information
2017-01-18 English
6-K Filing
Foreign Filer Report
2017-01-17 English